- Home
- CODI vs RGNX Comparison
CODI vs RGNX Comparison
Compare CODI & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODI
- RGNX
- Stock Information
- Founded
- CODI 2005
- RGNX 2008
- Country
- CODI United States
- RGNX United States
- Employees
- CODI N/A
- RGNX N/A
- Industry
- CODI Home Furnishings
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CODI Consumer Discretionary
- RGNX Health Care
- Exchange
- CODI Nasdaq
- RGNX Nasdaq
- Market Cap
- CODI 480.0M
- RGNX 424.8M
- IPO Year
- CODI 2006
- RGNX 2015
- Fundamental
- Price
- CODI $6.84
- RGNX $8.96
- Analyst Decision
- CODI Buy
- RGNX Strong Buy
- Analyst Count
- CODI 2
- RGNX 8
- Target Price
- CODI $26.00
- RGNX $31.75
- AVG Volume (30 Days)
- CODI 1.1M
- RGNX 603.1K
- Earning Date
- CODI 08-08-2025
- RGNX 08-08-2025
- Dividend Yield
- CODI 14.64%
- RGNX N/A
- EPS Growth
- CODI N/A
- RGNX N/A
- EPS
- CODI N/A
- RGNX N/A
- Revenue
- CODI $2,198,233,000.00
- RGNX $156,718,000.00
- Revenue This Year
- CODI $8.09
- RGNX $327.08
- Revenue Next Year
- CODI $7.62
- RGNX N/A
- P/E Ratio
- CODI N/A
- RGNX N/A
- Revenue Growth
- CODI 11.87
- RGNX 80.70
- 52 Week Low
- CODI $5.98
- RGNX $5.04
- 52 Week High
- CODI $24.59
- RGNX $15.36
- Technical
- Relative Strength Index (RSI)
- CODI 52.28
- RGNX 52.82
- Support Level
- CODI $6.13
- RGNX $8.14
- Resistance Level
- CODI $7.00
- RGNX $8.94
- Average True Range (ATR)
- CODI 0.27
- RGNX 0.49
- MACD
- CODI 0.15
- RGNX 0.07
- Stochastic Oscillator
- CODI 84.31
- RGNX 72.57
About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest
Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.